Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects-Reference-Cited by-同舟云学术

Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects

Published:2002-01-18 Issue:2 Volume:53 Page:155-162
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Frye Reginald F.,Branch Robert A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2002.01522.x/fullpdf

Reference41 articles.

1. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects;Guengerich;Chem Res Toxicol,1991

2. The possible role of the ethanol-inducible isozyme of cytochrome P450 in the metabolism and distribution of carbon disulfide;Snyderwine;Toxicol Appl Pharmacol,1988

3. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1;Kharasch;Clin Pharmacol Ther,1993

4. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans;Emery;J Pharmacol Exp Ther,1999

5. Single-dose disulfiram does not inhibit CYP2A6 activity;Kharasch;Clin Pharmacol Ther,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfiram—Mitigating Unintended Effects;Antibiotics;2023-01-28

2. Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports;Journal of Psychopharmacology;2023-01-26

3. Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options;Cells;2022-08-23

4. Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability;BMC Pharmacology and Toxicology;2022-07-22

5. Disulfiram and Cyanamide;NeuroPsychopharmacotherapy;2022